Beyond Air™ Schedules Fiscal Second Quarter 2020 Financial Results Conference Call and Webcast
Beyond Air, Inc. (XAIR)
Company Research
Source: GlobeNewswire
GARDEN CITY, N.Y. and REHOVOT, Israel, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including serious lung infections and pulmonary hypertension, today announced it will report financial results for its fiscal second quarter ended September 30, 2019 after the market close on Wednesday, November 6 and will host a conference call and webcast at 4:30pm Eastern Time. Conference Call & WebcastWednesday, November 6 @ 4:30pm ETDomestic:855-327-6837International:631-891-4304Passcode:13691695Webcast:http://public.viavid.com/index.php?id=136733 About Beyond Air, Inc. Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company developing a revolutionary NO Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the poten
Show less
Read more
Impact Snapshot
Event Time:
XAIR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XAIR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XAIR alerts
High impacting Beyond Air, Inc. news events
Weekly update
A roundup of the hottest topics
XAIR
News
- Beyond Air, Inc. (NASDAQ: XAIR) had its price target lowered by analysts at Truist Financial Co. from $10.00 to $8.00. They now have a "buy" rating on the stock.MarketBeat
- Beyond Air (XAIR) Upgraded to Buy: What Does It Mean for the Stock? [Yahoo! Finance]Yahoo! Finance
- Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and WarrantsGlobeNewswire
- Diabetic Foot Ulcers Market to Witness Upsurge Growth by 2032, Estimates DelveInsight | Leading Companies - Anterogen Co., Lavior Pharma, Vitruvian Medical Devices, Oneness Biotech Co., Energenesis Biomedical Co. [Yahoo! Finance]Yahoo! Finance
- Beyond Air, Inc. (NASDAQ:XAIR) Q3 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
XAIR
Earnings
- 2/12/24 - Beat
XAIR
Sec Filings
- 3/22/24 - Form 8-K
- 3/22/24 - Form 424B5
- 3/21/24 - Form 4
- XAIR's page on the SEC website